Target intelligence / Profile preview

Gram-negative bacterial outer membrane lipopolysaccharide lipid A and phospholipids (LPS/Lipid A)

Target
LPS/Lipid A
Molecular classification
Bacterial cell wall component, Lipopolysaccharide, Phospholipid, Other
01

Overview

The Gram-negative bacterial outer membrane is a specialized asymmetric bilayer where the inner leaflet is composed of phospholipids and the outer leaflet is predominantly lipopolysaccharide (LPS) (Nature Reviews Microbiology, 2010). Lipid A is the highly conserved, hydrophobic anchor of LPS and serves as the primary target for cationic antimicrobial peptides and lipopeptides like polymyxins (StatPearls, 2023). This target is essential for maintaining the structural integrity and selective permeability of the bacterial cell envelope, protecting the organism from environmental stressors and many antibiotics (Frontiers in Microbiology, 2020). In the context of human disease, Lipid A acts as a potent endotoxin, triggering a robust inflammatory response through the TLR4 signaling pathway, which can lead to sepsis and septic shock (Journal of Endotoxin Research, 2006). Drugs like polymyxins interact with this target by binding to the negatively charged phosphate groups of Lipid A and phospholipids, displacing stabilizing divalent cations and causing lethal membrane disruption (Journal of Antimicrobial Chemotherapy, 2014). Despite their efficacy against multidrug-resistant pathogens, targeting these membrane components is often associated with significant clinical challenges, including nephrotoxicity and the development of resistance through modification of the Lipid A structure (Clinical Microbiology Reviews, 2017).

Other names
LipopolysaccharideLipid AEndotoxinBacterial outer membrane lipidsLPS
02

Mechanism of action

Binding to negatively charged phosphate groups of lipid A and phospholipids, displacement of divalent cations (Mg2+ and Ca2+), and subsequent disruption of the outer and inner bacterial membranes (StatPearls, 2023; Journal of Antimicrobial Chemotherapy, 2014).

03

Biological functions

Immune responseCell deathStructural integrityPermeability barrierOther
04

Disease associations

InfectionInflammationSepsisSeptic shock
05

Safety considerations

NephrotoxicityNeurotoxicityNeuromuscular blockadeDevelopment of antimicrobial resistance (e.g., mcr genes) (Clinical Microbiology Reviews, 2017)
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

Endotoxin levelProcalcitoninLPS-binding protein (LBP)C-reactive protein (CRP)

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane lipopolysaccharide lipid A and phospholipids (LPS/Lipid A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane lipopolysaccharide lipid A and phospholipids (LPS/Lipid A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call